We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTES icon
1501
NetEase
NTES
$83.5B
$4.09M ﹤0.01%
42,839
-1,966
-4% -$187K
FBNC icon
1502
First Bancorp
FBNC
$2.66B
$4.09M ﹤0.01%
128,202
-74
-0.1% -$2.35K
PSN icon
1503
Parsons
PSN
$5.12B
$4.09M ﹤0.01%
50,012
-16,478
-25% -$1.29M
ICFI icon
1504
ICF International
ICFI
$1.54B
$4.08M ﹤0.01%
27,487
+247
+0.9% +$35.7K
RIOT icon
1505
Riot Platforms
RIOT
$8.02B
$4.07M ﹤0.01%
444,907
+140,961
+46% +$1.42M
RC
1506
Ready Capital
RC
$279M
$4.05M ﹤0.01%
495,448
-7,780
-2% -$66.3K
ZETA icon
1507
Zeta Global
ZETA
$6.42B
$4.05M ﹤0.01%
229,432
+41,688
+22% +$611K
HUN icon
1508
Huntsman Corp
HUN
$1.78B
$4.03M ﹤0.01%
177,112
-1,540
-0.9% -$37.5K
NVS icon
1509
Novartis
NVS
$293B
$4.03M ﹤0.01%
37,810
+499
+1% +$50.1K
VRE
1510
DELISTED
Veris Residential
VRE
$3.99M ﹤0.01%
265,956
-3,156
-1% -$47.1K
OMCL icon
1511
Omnicell
OMCL
$1.65B
$3.98M ﹤0.01%
147,188
+4,281
+3% +$124K
SQSP
1512
DELISTED
Squarespace, Inc.
SQSP
$3.98M ﹤0.01%
91,117
+4,712
+5% +$189K
RARE icon
1513
Ultragenyx Pharmaceutical
RARE
$2.55B
$3.97M ﹤0.01%
96,710
+5,047
+6% +$215K
SABR icon
1514
Sabre
SABR
$886M
$3.96M ﹤0.01%
1,484,339
+400,980
+37% +$1.12M
TGI
1515
DELISTED
Triumph Group
TGI
$3.95M ﹤0.01%
256,020
+4,075
+2% +$58K
SWTX
1516
DELISTED
SpringWorks Therapeutics
SWTX
$3.94M ﹤0.01%
104,656
+5,081
+5% +$214K
HCP
1517
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$3.94M ﹤0.01%
116,947
+9,296
+9% +$289K
STBA icon
1518
S&T Bancorp
STBA
$1.82B
$3.94M ﹤0.01%
117,876
-1,369
-1% -$42.8K
SLCA
1519
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$3.94M ﹤0.01%
254,698
-4,721
-2% -$69.5K
NTLA icon
1520
Intellia Therapeutics
NTLA
$1.57B
$3.92M ﹤0.01%
175,335
+8,797
+5% +$209K
AMWD
1521
DELISTED
American Woodmark
AMWD
$3.91M ﹤0.01%
49,752
-1,249
-2% -$113K
GSHD icon
1522
Goosehead Insurance
GSHD
$2.37B
$3.91M ﹤0.01%
68,064
+2,965
+5% +$178K
RPD icon
1523
Rapid7
RPD
$694M
$3.91M ﹤0.01%
90,430
+4,221
+5% +$176K
CCC
1524
CCC Intelligent Solutions
CCC
$3.83B
$3.91M ﹤0.01%
351,738
+72,106
+26% +$821K
NVEE
1525
DELISTED
NV5 Global
NVEE
$3.9M ﹤0.01%
167,756
+11,344
+7% +$265K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.